No Data
No Data
Improved Revenues Required Before CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Stock's 28% Jump Looks Justified
Those holding CASI Pharmaceuticals, Inc. (NASDAQ:CASI) shares would be relieved that the share price has rebounded 28% in the last thirty days, but it needs to keep going to repair the recent damage i
Sector Update: Health Care Stocks Advance in Afternoon Trading
Health care stocks were higher Wednesday afternoon, with the NYSE Health Care Index adding 1.1% and the Health Care Select Sector SPDR Fund (XLV) rising 1.3%. The iShares Biotechnology ETF (IBB) gaine
CASI Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
CASI Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
CASI Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 83.49% HC Wainwright & Co. $12 → $6 Maintains Buy 11/15/2023 266.97% HC Wainwright & Co. $10 →
Casi Pharma Spikes as FDA Clears Clinical Trial for Blood Disorder Therapy
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersSINTX Techs (NASDAQ:SINT) stock moved upwards by 143.1% to $0.13 during Wednesday's pre-market session. The company's market cap stands at $16.4 million. The company's, Q1 earnings came out 2 d
No Data